GeneStem Co., Ltd.;Osaka Urban Industry Promotion Center
发明人:
Hidekazu Tanaka,Motofumi Iguchi,Mari Yokoyama
申请号：
US15413343
公开号：
US09919039B2
申请日:
2017.01.23
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A Partner of Sld Five 1 (PSF1)-derived peptide that can induce a Cytotoxic T-Cell (CTL) response useful for a specific immunotherapy for cancer patients and a pharmaceutical composition for treating or preventing cancer, which contains the peptide according to the present invention are described.
